BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jin P, Sha R, Zhang Y, Liu L, Bian Y, Qian J, Qian J, Lin J, Ishimwe N, Hu Y, Zhang W, Liu Y, Yin S, Ren L, Wen LP. Blood Circulation-Prolonging Peptides for Engineered Nanoparticles Identified via Phage Display. Nano Lett 2019;19:1467-78. [PMID: 30730145 DOI: 10.1021/acs.nanolett.8b04007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Ni Q, Wang Y, Zhang Y, He H, Gao D, Ma X, Liang X. Nanoscale drug delivery systems for controllable drug behaviors by multi-stage barrier penetration. Journal of Controlled Release 2021;331:282-95. [DOI: 10.1016/j.jconrel.2020.08.045] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
2 Lima GM, Atrazhev A, Sarkar S, Sojitra M, Reddy R, Torres-Obreque K, de Oliveira Rangel-Yagui C, Macauley MS, Monteiro G, Derda R. DNA-Encoded Multivalent Display of Chemically Modified Protein Tetramers on Phage: Synthesis and in Vivo Applications. ACS Chem Biol 2021. [PMID: 34928124 DOI: 10.1021/acschembio.1c00835] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li M, Zhao X, Dai J, Yu Z. Peptide therapeutics and assemblies for cancer immunotherapy. Sci China Mater 2019;62:1759-81. [DOI: 10.1007/s40843-019-9451-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
4 Xu L, Wang Y, Zhu C, Ren S, Shao Y, Wu L, Li W, Jia X, Hu R, Chen R, Chen Z. Morphological transformation enhances Tumor Retention by Regulating the Self-assembly of Doxorubicin-peptide Conjugates. Theranostics 2020;10:8162-78. [PMID: 32724464 DOI: 10.7150/thno.45088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
5 Collado Camps E, van Lith SAM, Frielink C, Lankhof J, Dijkgraaf I, Gotthardt M, Brock R. CPPs to the Test: Effects on Binding, Uptake and Biodistribution of a Tumor Targeting Nanobody. Pharmaceuticals (Basel) 2021;14:602. [PMID: 34201507 DOI: 10.3390/ph14070602] [Reference Citation Analysis]
6 Paczesny J, Bielec K. Application of Bacteriophages in Nanotechnology. Nanomaterials (Basel) 2020;10:E1944. [PMID: 33003494 DOI: 10.3390/nano10101944] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
7 Sandra F, Khaliq NU, Sunna A, Care A. Developing Protein-Based Nanoparticles as Versatile Delivery Systems for Cancer Therapy and Imaging. Nanomaterials (Basel) 2019;9:E1329. [PMID: 31527483 DOI: 10.3390/nano9091329] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
8 Mainini F, Bonizzi A, Sevieri M, Sitia L, Truffi M, Corsi F, Mazzucchelli S. Protein-Based Nanoparticles for the Imaging and Treatment of Solid Tumors: The Case of Ferritin Nanocages, a Narrative Review. Pharmaceutics 2021;13:2000. [PMID: 34959283 DOI: 10.3390/pharmaceutics13122000] [Reference Citation Analysis]
9 Jin P, Wang L, Sha R, Liu L, Qian J, Ishimwe N, Zhang W, Qian J, Zhang Y, Wen L. A blood circulation-prolonging peptide anchored biomimetic phage-platelet hybrid nanoparticle system for prolonged blood circulation and optimized anti-bacterial performance. Theranostics 2021;11:2278-96. [PMID: 33500725 DOI: 10.7150/thno.49781] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Dong X, Pan P, Zheng DW, Bao P, Zeng X, Zhang XZ. Bioinorganic hybrid bacteriophage for modulation of intestinal microbiota to remodel tumor-immune microenvironment against colorectal cancer. Sci Adv 2020;6:eaba1590. [PMID: 32440552 DOI: 10.1126/sciadv.aba1590] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
11 Zhang B, Tang G, He J, Yan X, Fan K. Ferritin nanocage: A promising and designable multi-module platform for constructing dynamic nanoassembly-based drug nanocarrier. Adv Drug Deliv Rev 2021;176:113892. [PMID: 34331986 DOI: 10.1016/j.addr.2021.113892] [Reference Citation Analysis]
12 Taleb M, Atabakhshi-Kashi M, Wang Y, Rezvani Alanagh H, Farhadi Sabet Z, Li F, Cheng K, Li C, Qi Y, Nie G, Ying Z. Bifunctional Therapeutic Peptide Assembled Nanoparticles Exerting Improved Activities of Tumor Vessel Normalization and Immune Checkpoint Inhibition. Adv Healthc Mater 2021;10:e2100051. [PMID: 34021735 DOI: 10.1002/adhm.202100051] [Reference Citation Analysis]
13 Connors J, Bell MR, Marcy J, Kutzler M, Haddad EK. The impact of immuno-aging on SARS-CoV-2 vaccine development. Geroscience 2021;43:31-51. [PMID: 33569701 DOI: 10.1007/s11357-021-00323-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
14 Yin S, Davey K, Dai S, Liu Y, Bi J. A critical review of ferritin as a drug nanocarrier: Structure, properties, comparative advantages and challenges. Particuology 2022;64:65-84. [DOI: 10.1016/j.partic.2021.04.020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Peng X, Chen K, Liu W, Cao X, Wang M, Tao J, Tian Y, Bao L, Lu G, Teng Z. Soft Mesoporous Organosilica Nanoplatforms Improve Blood Circulation, Tumor Accumulation/Penetration, and Photodynamic Efficacy. Nanomicro Lett 2020;12:137. [PMID: 34138135 DOI: 10.1007/s40820-020-00465-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
16 Farshbaf M, Valizadeh H, Panahi Y, Fatahi Y, Chen M, Zarebkohan A, Gao H. The impact of protein corona on the biological behavior of targeting nanomedicines. Int J Pharm 2022;614:121458. [PMID: 35017025 DOI: 10.1016/j.ijpharm.2022.121458] [Reference Citation Analysis]